Tumor Angiogenesis and Anti-Angiogenic Strategies for Cancer Treatment
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Tumor Angiogenesis and Anti-Angiogenic Strategies for Cancer Treatment
Authors
Keywords
-
Journal
Journal of Clinical Medicine
Volume 9, Issue 1, Pages 84
Publisher
MDPI AG
Online
2019-12-30
DOI
10.3390/jcm9010084
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Role of Angiogenesis and Pro-Angiogenic Exosomes in Regenerative Dentistry
- (2019) Alina-Andreea Zimta et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Therapeutic angiogenesis: From conventional approaches to recent nanotechnology-based interventions
- (2019) Robin Augustine et al. Materials Science & Engineering C-Materials for Biological Applications
- Angiogenesis in Pancreatic Cancer: Pre-Clinical and Clinical Studies
- (2019) Tiziana Annese et al. Cancers
- The Role of Fibrinolytic Regulators in Vascular Dysfunction of Systemic Sclerosis
- (2019) Yosuke Kanno INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment
- (2019) Ming Yi et al. Molecular Cancer
- Antitumor effects of Endostar(rh-endostatin) combined with gemcitabine in different administration sequences to treat Lewis lung carcinoma
- (2019) Yuan Li et al. Cancer Management and Research
- Antiangiogenic properties of nanoparticles: a systematic review
- (2019) Brhaish Ali Saeed et al. International Journal of Nanomedicine
- Heterogeneity of Vascular Endothelial Cells, De Novo Arteriogenesis and Therapeutic Implications in Pancreatic Neuroendocrine Tumors
- (2019) Bin Ren et al. Journal of Clinical Medicine
- Aptamer-based biosensors and nanosensors for the detection of vascular endothelial growth factor (VEGF): A review
- (2018) Sadegh Dehghani et al. BIOSENSORS & BIOELECTRONICS
- Angiogenesis in peripheral arterial disease
- (2018) Chakradhari Inampudi et al. CURRENT OPINION IN PHARMACOLOGY
- VEGF (Vascular Endothelial Growth Factor) and Fibrotic Lung Disease
- (2018) Shaney Barratt et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Positive and Negative Regulation of Angiogenesis by Soluble Vascular Endothelial Growth Factor Receptor-1
- (2018) Cristina Failla et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Endogenous Antiangiogenic Factors in Chronic Kidney Disease: Potential Biomarkers of Progression
- (2018) Katsuyuki Tanabe et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Immunohistochemical evaluation of tumor angiogenesis and the role of mast cells in oral squamous cell carcinoma
- (2018) Arpita Kabiraj et al. Journal of Cancer Research and Therapeutics
- Important signals regulating coronary artery angiogenesis
- (2018) Sara Shoeibi et al. MICROVASCULAR RESEARCH
- Platelet-derived growth factor-C and -D in the cardiovascular system and diseases
- (2018) Chunsik Lee et al. MOLECULAR ASPECTS OF MEDICINE
- Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
- (2018) Dai Fukumura et al. Nature Reviews Clinical Oncology
- Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa
- (2018) Kabir A. Khan et al. Nature Reviews Clinical Oncology
- Nanotherapeutic approaches targeting angiogenesis and immune dysfunction in tumor microenvironment
- (2018) Sadaf Hameed et al. Science China-Life Sciences
- Delayed recognition of Judah Folkman’s hypothesis on tumor angiogenesis: when a Prince awakens a Sleeping Beauty by self-citation
- (2018) Adil El Aichouchi et al. SCIENTOMETRICS
- Tumor angiogenesis and anti‑angiogenic gene therapy for cancer (Review)
- (2018) Tinglu Li et al. Oncology Letters
- Current Challenges of Cancer Anti-angiogenic Therapy and the Promise of Nanotherapeutics
- (2018) Ahmed M.E. Abdalla et al. Theranostics
- Tumor Angiogenesis: A Key Target for Cancer Therapy
- (2018) Dieter Marmé Oncology Research and Treatment
- Anti-Angiogenics: Current Situation and Future Perspectives
- (2018) Katja Zirlik et al. Oncology Research and Treatment
- Pro- and antiangiogenic therapies: current status and clinical implications
- (2018) Ruslan Rust et al. FASEB JOURNAL
- Modelling skin wound healing angiogenesis: A review
- (2018) Ana Guerra et al. JOURNAL OF THEORETICAL BIOLOGY
- Apatinib combined with oral etoposide in patients with platinum-resistant or platinum-refractory ovarian cancer (AEROC): a phase 2, single-arm, prospective study
- (2018) Chun-Yan Lan et al. LANCET ONCOLOGY
- Recent advances in anti-angiogenic nanomedicines for cancer therapy
- (2018) Pravin Bhattarai et al. Nanoscale
- Enhanced antitumor and anti-angiogenic effects of metronomic Vinorelbine combined with Endostar on Lewis lung carcinoma
- (2018) Rong-Sheng Qin et al. BMC CANCER
- Tumor microenvironment: Interactions and therapy
- (2018) Masoud Najafi et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Beyond endothelial cells: Vascular endothelial growth factors in heart, vascular anomalies and placenta
- (2018) Johanna P. Laakkonen et al. VASCULAR PHARMACOLOGY
- Targeting VEGF pathway to normalize the vasculature: an emerging insight in cancer therapy
- (2018) Jingbiao Wu et al. OncoTargets and Therapy
- Efficacy and toxicities of gemcitabine and cisplatin combined with endostar in advanced thymoma and thymic carcinoma
- (2018) Yang Wang et al. Thoracic Cancer
- Monitoring of tumor vascular normalization: the key points from basic research to clinical application
- (2018) Wei Li et al. Cancer Management and Research
- Angiogenic growth factors in myocardial infarction: a critical appraisal
- (2017) Hemalatha Thiagarajan et al. HEART FAILURE REVIEWS
- Biological Pathways Involved in Tumor Angiogenesis and Bevacizumab Based Anti-Angiogenic Therapy with Special References to Ovarian Cancer
- (2017) Vera Loizzi et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Platelet Factor 4 Binds to Vascular Proteoglycans and Controls Both Growth Factor Activities and Platelet Activation
- (2017) Megan S. Lord et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Acquired tumor resistance to antiangiogenic therapy: Mechanisms at a glance
- (2017) ShaghayeghHaghjooy Javanmard et al. Journal of Research in Medical Sciences
- The Angiopoietin-Tie2 Signaling Axis in Systemic Inflammation
- (2017) Samir M. Parikh JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- OA11.07 Combining Anti-Angiogenesis and Immunotherapy Enhances Antitumor Effect by Promoting Immune Response in Lung Cancer
- (2017) Sha Zhao et al. Journal of Thoracic Oncology
- The Potential of Combined Immunotherapy and Antiangiogenesis for the Synergistic Treatment of Advanced NSCLC
- (2017) Christian Manegold et al. Journal of Thoracic Oncology
- The Role of PDGFs and PDGFRs in Colorectal Cancer
- (2017) Roberta M. Manzat Saplacan et al. MEDIATORS OF INFLAMMATION
- Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming
- (2017) Lin Tian et al. NATURE
- Combined antiangiogenic and anti–PD-L1 therapy stimulates tumor immunity through HEV formation
- (2017) Elizabeth Allen et al. Science Translational Medicine
- Enzymes involved in tumor-driven angiogenesis: A valuable target for anticancer therapy
- (2017) Biagio Ricciuti et al. SEMINARS IN CANCER BIOLOGY
- Molecular regulation and role of angiogenesis in reproduction
- (2017) Momchil Rizov et al. Taiwanese Journal of Obstetrics & Gynecology
- Angiogenic factors: role in esophageal cancer, a brief review
- (2017) Kátia Ladeira et al. Esophagus
- Cross-talk mechanism between endothelial cells and hepatocellular carcinoma cells via growth factors and integrin pathway promotes tumor angiogenesis and cell migration
- (2017) Tang Feng et al. Oncotarget
- Endostar in combination with postoperative adjuvant chemotherapy prolongs the disease free survival of stage IIIA NSCLC patients with high VEGF expression
- (2017) Zhiwei Chen et al. Oncotarget
- Quantifying the effects of antiangiogenic and chemotherapy drug combinations on drug delivery and treatment efficacy
- (2017) Sirin Yonucu et al. PLoS Computational Biology
- Gastrointestinal cancer cells treatment with bevacizumab activates a VEGF autoregulatory mechanism involving telomerase catalytic subunit hTERT via PI3K-AKT, HIF-1α and VEGF receptors
- (2017) Nadine Mahfouz et al. PLoS One
- Endostatin and endorepellin: A common route of action for similar angiostatic cancer avengers
- (2016) Chiara Poluzzi et al. ADVANCED DRUG DELIVERY REVIEWS
- Commentary on Folkman: “Tumor Angiogenesis Factor”
- (2016) Rebecca G. Bagley CANCER RESEARCH
- Vasculogenesis and Its Cellular Therapeutic Applications
- (2016) Anna Ratajska et al. CELLS TISSUES ORGANS
- Therapeutic angiogenesis by vascular endothelial growth factor supplementation for treatment of renal disease
- (2016) Omar C. Logue et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Angiopoietins and diabetic nephropathy
- (2016) Luigi Gnudi DIABETOLOGIA
- Therapeutic application of anti-angiogenic nanomaterials in cancers
- (2016) Sudip Mukherjee et al. Nanoscale
- Vascular endothelial growth factor and diabetic macular edema
- (2016) David R. Lally et al. SURVEY OF OPHTHALMOLOGY
- Vascularization and Angiogenesis in Tissue Engineering: Beyond Creating Static Networks
- (2016) Jeroen Rouwkema et al. TRENDS IN BIOTECHNOLOGY
- The VEGF rise in blood of bevacizumab patients is not based on tumor escape but a host-blockade of VEGF clearance
- (2016) Lejla Alidzanovic et al. Oncotarget
- Angiopoietin-1 and Angiopoietin-2 in metabolic disorders: therapeutic strategies to restore the highs and lows of angiogenesis in diabetes
- (2016) A. M. Isidori et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Hepatocyte growth factor (HGF) and hemodialysis: physiopathology and clinical implications
- (2015) Carmelo Libetta et al. Clinical and Experimental Nephrology
- Final overall survival and safety analysis of OCEANS, a phase 3 trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent ovarian cancer
- (2015) Carol Aghajanian et al. GYNECOLOGIC ONCOLOGY
- Current therapies and investigational drugs for peripheral arterial disease
- (2015) Jun-ichi Suzuki et al. HYPERTENSION RESEARCH
- Targeting Hypoxia-Inducible Factor 1 to Stimulate Tissue Vascularization
- (2015) Gregg L. Semenza JOURNAL OF INVESTIGATIVE MEDICINE
- Hypoxia-Inducible Factor-1 in Physiological and Pathophysiological Angiogenesis: Applications and Therapies
- (2015) Agnieszka Zimna et al. Biomed Research International
- Hypoxia-Inducible Factor as an Angiogenic Master Switch
- (2015) Takuya Hashimoto et al. Frontiers in Pediatrics
- Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
- (2014) Eric Pujade-Lauraine et al. JOURNAL OF CLINICAL ONCOLOGY
- The Impact of the Immune System on Tumor: Angiogenesis and Vascular Remodeling
- (2014) Christian Stockmann et al. Frontiers in Oncology
- Molecular Basis for the Regulation of Angiogenesis by Thrombospondin-1 and -2
- (2013) P. R. Lawler et al. Cold Spring Harbor Perspectives in Medicine
- Anti-VEGF/VEGFR Therapy for Cancer: Reassessing the Target
- (2012) B. Sitohy et al. CANCER RESEARCH
- The vascular endothelial growth factor (VEGF)-E encoded by orf virus regulates keratinocyte proliferation and migration and promotes epidermal regeneration
- (2012) Lyn M. Wise et al. CELLULAR MICROBIOLOGY
- Platelets in Angiogenesis
- (2012) Johannes Patzelt et al. Current Vascular Pharmacology
- RIBBON-1: Randomized, Double-Blind, Placebo-Controlled, Phase III Trial of Chemotherapy With or Without Bevacizumab for First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative, Locally Recurrent or Metastatic Breast Cancer
- (2011) Nicholas J. Robert et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study of Bevacizumab Plus Docetaxel Compared With Placebo Plus Docetaxel for the First-Line Treatment of Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer
- (2010) David W. Miles et al. JOURNAL OF CLINICAL ONCOLOGY
- Independent Review of E2100: A Phase III Trial of Bevacizumab Plus Paclitaxel Versus Paclitaxel in Women With Metastatic Breast Cancer
- (2009) Robert Gray et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of the platelet chemokine platelet factor 4 (PF4) in hemostasis and thrombosis
- (2009) M. Anna Kowalska et al. THROMBOSIS RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search